Myriad Genetics (MYGN)
NASDAQ:MYGN
Holding MYGN?
Track your performance easily

Myriad Genetics (MYGN) Cash flow

349 Followers

Myriad Genetics Cash Flow

MYGN's free cash flow for Q2 2024 was $-2.60M. For the 2024 fiscal year, MYGN's free cash flow was decreased by $-22.50M and operating cash flow was $2.60M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Jun 20Jun 19
Operating Cash Flow
$ -92.80M$ -110.90M$ -106.30M$ 18.20M$ 60.70M$ 83.70M
Investing Cash Flow
$ -28.00M$ 31.90M$ -77.50M$ 274.40M$ 19.30M$ -286.40M
Financing Cash Flow
$ 113.00M$ 152.90M$ -8.00M$ -150.60M$ -10.00M$ 182.30M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 432.40M$ 140.90M$ 66.40M$ 258.40M$ 163.70M$ 93.20M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 117.60M$ 117.60M----
Issuance Of Debt
$ -700.00K$ 38.10M$ -700.00K$ -226.40M$ 0.00$ 340.00M
Repayment Of Debt
$ -80.50M$ -41.90M$ -700.00K$ -226.40M$ -8.60M$ -115.00M
Free Cash Flow
$ -60.90M$ -174.10M$ -151.60M$ 200.00K$ 50.50M$ 75.10M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Myriad Genetics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis